Prevention of heart failure — is there a choice?
Open Access
- 29 October 2026
- journal article
- Published by Intermedservice Ltd in Systemic Hypertension
- Vol. 23 (3) , 5-11
Abstract
Effective treatment of arterial hypertension (AH) is important for preventing or delaying the development of chronic heart failure (CHF) and reducing associated hospitalizations and mortality. Despite the proven benefits of AH control, epidemiological data demonstrate that the effectiveness of antihypertensive therapy remains low at the population level. Combination therapy at the start of hypertension treatment is recommended for the majority of patients, and the combination of an angiotensin II receptor blocker and a diuretic is one of the most rational choices. This review systematizes studies on the use of azilsartan medoxomil with chlorthalidone in patients with CHF or at high risk of its development.Keywords
This publication has 38 references indexed in Scilit:
- Sex-based differences in left ventricular mass reduction across angiotensin II receptor blockers in patients with heart failure with preserved or mildly reduced ejection fractionHeart and Vessels, 2024
- Hypertension and Heart FailureCardiology Clinics, 2022
- Universal Definition and Classification of Heart FailureJournal of Cardiac Failure, 2021
- Prevalence, Neurohormonal Correlates, and Prognosis of Heart Failure Stages in the CommunityJACC: Heart Failure, 2016
- Azilsartan, but not Candesartan Improves Left Ventricular Diastolic Function in Patients with Hypertension and Heart FailureInternational Journal of Gerontology, 2015
- Diagnosis of Heart Failure with Preserved Ejection FractionHeart Failure Clinics, 2014
- Studies on Left Ventricular Hypertrophy Regression in Arterial Hypertension: A Clear Message for the Clinician?American Journal of Hypertension, 2008
- Regression of Electrocardiographic Left Ventricular Hypertrophy During Antihypertensive Treatment and the Prediction of Major Cardiovascular EventsJAMA, 2004
- A meta-analysis of the effects of treatment on left ventricular mass in essential hypertensionThe American Journal of Medicine, 2003
- Prevention of Heart Failure by Antihypertensive Drug Treatment in Older Persons With Isolated Systolic HypertensionJAMA, 1997